Continuation Breakout Analysis — 2026-10-21

Overview

Today’s scan produced 16 continuation breakout signals against a Cautious-Bearish regime backdrop, with breadth sitting at just 38.5% above the SMA-40. That combination — elevated signal count but a defensive macro tape — tells us to be selective rather than aggressive. The leadership picture is clear: Health Care (2.8% ATR%), Consumer Staples, and Utilities are leading, while Technology, Real Estate, and Financials are lagging. Three of our top candidates (TMO, WST, DGX) sit in Medical, aligning directly with sector leadership, which boosts conviction on those names despite the broader risk-off tone.

Sector mix today is fairly diverse — Medical, Telecom, Software, Finance, and Metals are all represented — so this reads more like broad-based opportunistic strength than a single-theme trade. Given the regime headwinds, we’re capping conviction at a Quality Score of 3/5: solid setups exist, but chase risk is elevated and position sizing should stay conservative.

Top 5 Picks

TMO ($694.02) — Medical / Research

Open full analysis on WaveFinder →

TMO is the standout today. It’s trading in a leading sector (Health Care), posting a 1.8 RVOL with positive ATR%-M of 2.8 — confirming expanding volatility on the upside. Price sits comfortably between zones with the daily demand shelf (648.29–654.80, strength 6.8) well below as a safety net. Backed by 4,831 institutional funds, this is the highest-conviction name on the list.

Entry	Stop	Target
$695.00	$645.00	$750.00

Institutional Backing: 4,831 funds (INST).

WST ($393.48) — Medical / Products

WST shows the strongest momentum reading of the group with ATR%-M at 4.2, well-aligned with the leading Health Care sector. The 4h demand zone (361.00–365.59) is a reasonable pullback floor, with monthly supply far overhead near 442–475, leaving plenty of runway.

Entry	Stop	Target
$395.00	$360.00	$440.00

Institutional Backing: 2,164 funds (INST).

DGX ($238.93) — Medical / Services

DGX is sitting right at its weekly demand zone (228.57–235.02, strength 6.4), only 1.64% away — a clean, low-risk entry point. RVOL of 1.2 confirms participation, and its Medical classification keeps it in the sector-leadership sweet spot.

Entry	Stop	Target
$239.00	$227.00	$255.00

Institutional Backing: 2,317 funds (INST).

CIEN ($361.34) — Telecom / Equipment

Open full analysis on WaveFinder →

CIEN’s 5.7% move stands out, and price is parked right at a daily demand zone (340.52–354.92, strength 6.8), making this a reaction-point breakout rather than a late chase. Supply sits far above near 446.93–466.66, giving a wide reward window, though ATR%-M is mildly negative (-0.5), so size should stay moderate.

Entry	Stop	Target
$362.00	$339.00	$420.00

Institutional Backing: 2,705 funds (INST), Bucket B2.

PLTR ($201.72) — Software / Enterprise

Open full analysis on WaveFinder →

PLTR carries the largest institutional footprint in today’s scan (3,777 funds) and a positive ATR%-M of 2.4 despite Technology being a lagging sector. RVOL is sub-1 at 0.9, so confirmation is lighter — treat this as a smaller, opportunistic position rather than a core allocation.

Entry	Stop	Target
$202.00	$188.00	$225.00

Institutional Backing: 3,777 funds (INST), Bucket B1, B2.

Honorable Mentions

• SEZL ($136.22): Strong 4.6% move but thin RVOL (0.8) and no institutional confirmation — speculative only.
• MSI ($467.50): Weak 0.9% gain sitting right at supply (478.92–492.88) — resistance risk outweighs reward here.
• RS ($421.07): High RVOL (1.9) but at_supply with just 0.42% distance to resistance — poor risk/reward for new entries.
• ISRG ($428.12): Down 2.3% with RVOL 2.3 at_supply — this is distribution, not continuation; avoid.
• DDOG ($273.09): Biggest % move (6.5%) but squeezed between demand and nearby 30m supply (286.69–288.67) — limited near-term upside.

Strategy Summary

Today’s setups skew toward Medical names riding genuine sector leadership (TMO, WST, DGX), supplemented by two higher-beta, institutionally-backed names (CIEN, PLTR) offering asymmetric reward if the broader tape stabilizes. With breadth under 40% and a Cautious-Bearish regime, we’re capping overall conviction at 3/5 — favor demand-zone entries with tight stops over chasing extended moves, and keep position sizes conservative until breadth and sector breadth improve.

Signals